Deposition of collagen IV and aggrecan in leptomeningeal arteries of hereditary brain haemorrhage with amyloidosisSNORRADOTTIR, Asbjorg Osk; ISAKSSON, Helgi J; KAESER, Stephan A et al.Brain research. 2013, Vol 1535, pp 106-114, issn 0006-8993, 9 p.Article

Transthyretin Deposition in Familial Amyloidotic Polyneuropathy : Transthyretin: A Small Protein in the Big World of AmyloidosesSARAIVA, M. J; MAGALHAES, J; FERREIRA, N et al.Current medicinal chemistry. 2012, Vol 19, Num 15, pp 2304-2311, issn 0929-8673, 8 p.Article

Amyloïdose de type β2-microglobuline révélée par une perforation intestinale chez une hémodialysée chronique = Beta 2-microglobulin amyloidosis presenting as intestinal perforation in a haemodialysis patientFARAH-KLIBI, F; FERCHICHI, L; JARBOUI, S et al.La Revue de médecine interne (Paris). 2007, Vol 28, Num 4, pp 269-271, issn 0248-8663, 3 p.Article

Pseudoachalasie liée à l'amylose traitée par toxine botulique = Pseudoachalasia due to amyloidosis treated by botulinum toxinBENJELLOUN, M; PENG, C.-L; HERITIER, F et al.La Revue de médecine interne (Paris). 2007, Vol 28, Num 3, pp 188-190, issn 0248-8663, 3 p.Article

Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosisABRAHAM, Roshini S; BALLMAN, Karla V; DISPENZIERI, Angela et al.Blood. 2005, Vol 105, Num 2, pp 794-803, issn 0006-4971, 10 p.Article

Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases : cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formationRÖCKEN, C; MENARD, R; BÜHLING, F et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 6, pp 808-815, issn 0003-4967, 8 p.Article

Toxic intrathoracic goiter and mediastinal lymphadenopathy: An unusual presentation of systemic primary al amyloidosisDE SAEDELEER, B; POPPE, K; LACOR, P et al.Acta Clinica Belgica. 2003, Vol 58, Num 1, pp 46-49, issn 0001-5512, 4 p.Article

Uptake of technetium 99m HDP in cardiac amyloidosisKULHANEK, Jan; MOVAHED, Assad.The International journal of cardiovascular imaging. 2003, Vol 19, Num 3, pp 225-227, issn 1569-5794, 3 p.Article

Amylose localisée du cavum = Localised amyloidosis of the cavumWACRENIER, A; FAYOUX, P; AUGUSTO, D et al.La Presse médicale (1983). 2003, Vol 32, Num 3, pp 114-116, issn 0755-4982, 3 p.Article

Manifestations cardiaques de l'amylose par dépôts de transthyrétine et d'apolipoproéine A1: À propos de 3 cas familiaux = Cardiac manifestations of amyloidosis by deposits of transthyretin and apolipoprotein A1LAFITTE, S; LAFITTE, M; PERRON, J.-M et al.Archives des maladies du coeur et des vaisseaux. 2003, Vol 96, Num 6, pp 631-635, issn 0003-9683, 5 p.Article

A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivoANDO, Yukio; HARAOKA, Katsuki; TAKESAKO, Kazuhiro et al.Laboratory investigation. 2003, Vol 83, Num 12, pp 1751-1759, issn 0023-6837, 9 p.Article

Jaw claudication in primary amyloidosis: Unusual presentation of a rare diseaseCHURCHILL, Christopher H; ABRIL, Andy; KRISHNA, Murli et al.Journal of rheumatology. 2003, Vol 30, Num 10, pp 2283-2286, issn 0315-162X, 4 p.Article

Advanced glycation end product-modified β₂-Microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosisFUJIMOTO, Norihiro; YAJIMA, Mayumi; OHNISHI, Yoshihiro et al.Journal of investigative dermatology. 2002, Vol 118, Num 3, pp 479-484, issn 0022-202XArticle

Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy studyPFEIFER, L. A; WHITE, L. R; ROSS, G. W et al.Neurology. 2002, Vol 58, Num 11, pp 1629-1634, issn 0028-3878Article

Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosisSANCHORAWALA, Vaishali; WRIGHT, Daniel G; SELDIN, David C et al.British journal of haematology. 2002, Vol 117, Num 4, pp 886-889, issn 0007-1048Article

Progressive generalized alopecia due to systemic amyloidosisLUTZ, Michael E; PITTELKOW, Mark R.Journal of the American Academy of Dermatology. 2002, Vol 46, Num 3, pp 434-436, issn 0190-9622Article

Transthyretin Val 107 in a Japanese patient with familial amyloid polyneuropathyNANRI, Kazunori; UTSUMI, Hiroya; YAMADA, Masahito et al.Journal of the neurological sciences. 2002, Vol 198, Num 1-2, pp 93-96, issn 0022-510XArticle

Amyloid formation in rat transthyretin: effect of oxidative stressTAJIRI, Takahiro; ANDO, Yukio; IMASATO, Akira et al.Clinica chimica acta. 2002, Vol 323, Num 1-2, pp 129-137, issn 0009-8981, 9 p.Article

Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: Clinical and pathological featuresCABALLERIA, Joan; BRUGUERA, Miquel; SOLE, Manel et al.The American journal of gastroenterology. 2001, Vol 96, Num 6, pp 1872-1876, issn 0002-9270Article

Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimenSHTRASBURG, Shmuel; PRAS, Mordechai; GAL, Rivka et al.The Journal of laboratory and clinical medicine. 2001, Vol 138, Num 2, pp 107-111, issn 0022-2143Article

Nodular localized primary cutaneous amyloidosis : a long-term follow-up studyWOOLLONS, A; BLACK, M. M.British journal of dermatology (1951). 2001, Vol 145, Num 1, pp 105-109, issn 0007-0963Article

Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu)ELLIE, E; CAMOU, F; VITAL, A et al.Neurology. 2001, Vol 57, Num 1, pp 135-137, issn 0028-3878Article

Primary systemic amyloidosis: A cause of malabsorption syndromeHAYMAN, Suzanne R; LACY, Martha Q; KYLE, Robert A et al.The American journal of medicine. 2001, Vol 111, Num 7, pp 535-540, issn 0002-9343Article

XLIVe Congrès de la Société Nationale Française de Médecine InterneLa Revue de médecine interne (Paris). 2001, Vol 22, issn 0248-8663, 201 p., SUP1Conference Proceedings

Clinical quiz ; rhumatoid athritis-associated intestinal amyloidosisFACCHINI, S; LEPORE, L; MALORGIO, C et al.Journal of pediatric gastroenterology and nutrition. 2001, Vol 32, Num 1, issn 0277-2116, 4,99 [2 p.]Article